- Seen : 2468 View
- established year : 2012
- Phone : 00982188937433
- Fax : 00982188896595
- Instagram : rooyan.darou
- website : http://www.rooyandarou.com/
- E-mail : info@rooyandarou.com
- youtube link : https://www.youtube.com/channel/UC8cVTS15DJqqmaoAJ9rn6jg
- Address : iran -tehran -nejatollahi -salman pak -Rooyan Darou Co
-
About us :
“ROOYAN DAROU Pharmaceutical company “founded and managed by one of Iran’s strongest and most successful technical & commercial teams in 2004 initially named “Jamedat Afagh” being operated by 150 staffs for acting in local and global pharmaceutical market .
“ROOYAN DAROU” is a manufacturer, Distributor, Importer and exporter of poultry and v ...
More -
About us :
“ROOYAN DAROU Pharmaceutical company “founded and managed by one of Iran’s strongest and most successful technical & commercial teams in 2004 initially named “Jamedat Afagh” being operated by 150 staffs for acting in local and global pharmaceutical market .
“ROOYAN DAROU” is a manufacturer, Distributor, Importer and exporter of poultry and veterinary medicine products and nowadays human medicine products also In 2007 after various researches and developments it was decided to expand 4 separate phases until 2015.
Phase 1 of development plan in old factory was for renovation in a space more than 5000 square meters consisting manufacturing hall, warehouses, installation of laboratories adjusting by incidence European GMP standards. This took place in less than 9 months in “industrial town” located east of Semnan nearest state to Tehran.
In 2008 phase 1 of our developing plan successfully targeted operating production lines with the capacity of producing annually 6 million liters of oral solution and 5000 Metric tons of powder & disinfectants, this helped achieving ISO 9002 and GMP.
These successful achievements over the past 2 years gave us access to local & global markets while operating phase 2 in 2011 which includes production lines of veterinary injectables in a space of more than 12000 square meters.
After utilization of phase 1 & 2 and in near future we would commence operating phase 3 & 4 which includes human injectables and oral medicines, veterinary vaccines, hi-tech and biotech products while aiming to transform the company becoming one of the biggest pharmaceutical companies throughout middle east until 2015.
Close
